Effect of Focused Ultrasound on Abdominal and Intrahepatic Fat in Patients With Non-alcoholic Fatty Liver Disease
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Fatty Liver
Related studies linked through entity extraction aliases.
A Pilot Study to Explore the Role of Gut Flora in Fatty Liver
- Status
- WITHDRAWN
- Phase
- N/A
Long-term Follow Up of Patients in the Birmingham and Lambeth Liver Evaluation Strategies (BALLETS) Study
- Status
- COMPLETED
- Phase
- N/A
Diabetes, Exercise and Liver Fat (DELIVER)
- Status
- COMPLETED
- Phase
- NA
Omega-3 Supplementation for LIver VolumE Reduction Study (OLIVER) Study
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Fatty Liver Imaging Project ( FLIP ) Patient Pilot Study
- Status
- WITHDRAWN
- Phase
- NA
Effects of Testosterone Undecanoate vs Placebo on Intrahepatic Fat Content in Overweight/Obese Men With T2DM or Prediabetes and Hypogonadism
- Status
- RECRUITING
- Phase
- PHASE4
A Pathophysiological Study of the Postprandial Human Liver (PLS)
- Status
- UNKNOWN
- Phase
- N/A
The Effects of Low Carbohydrate Diet on Liver Fat Content and Mitochondrial Fluxes
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
A Self Selected Population Study of Undiagnosed NAFLD and NASH, Using an Echosens FibroScan, in at Risk Populations
- Status
- COMPLETED
- Phase
- N/A
An Evaluation of the Safety and Efficacy of Nitazoxanide on Collagen Turnover in NASH Patients With Fibrosis
- Status
- COMPLETED
- Phase
- PHASE2
Antidiabetic Drugs for Steatotic Liver Disease
- Status
- COMPLETED
- Phase
- PHASE4
Effect of Probiotic and Smectite Gel on NAFLD
- Status
- COMPLETED
- Phase
- NA
Liver Steatosis and Stiffness in HIV
- Status
- UNKNOWN
- Phase
- N/A
Study to Assess the Relationship Between Daily Dosing of NRPT and Changes in Liver Fat in Healthy Volunteers
- Status
- COMPLETED
- Phase
- NA
Study of Gemcabene in Adults With FPLD
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Early Tracking of Childhood Health Determinants (ETCHED) Study
- Status
- RECRUITING
- Phase
- N/A
Effect of Fatty Liver on TCA Cycle Flux and the Pentose Phosphate Pathway
- Status
- COMPLETED
- Phase
- N/A
Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk
- Status
- COMPLETED
- Phase
- PHASE2
Effect on Liver Fat and Metabolic Parameters When Switching a Protease Inhibitor or Efavirenz to Raltegravir
- Status
- COMPLETED
- Phase
- PHASE4